116 related articles for article (PubMed ID: 2834480)
1. [Biological activity of enoxaprine (PK 10169) in hemodialysis. A dose study].
Pouzol P; Polack B; Dechelette E; Jurkovitz C; Cusin E
J Mal Vasc; 1987; 12 Suppl B():108-10. PubMed ID: 2834480
[TBL] [Abstract][Full Text] [Related]
2. [Is enoxaparine (PK 10169) a good anticoagulant in chronic hemodialysis?].
Briquel ME; Kessler M; André E; Huu TC; Alexandre P; Renoult E; Jonon B
J Mal Vasc; 1987; 12 Suppl B():111-3. PubMed ID: 2834481
[TBL] [Abstract][Full Text] [Related]
3. Use of single dose low-molecular-weight heparin in long hemodialysis.
Lai KN; Ho K; Li M; Szeto CC
Int J Artif Organs; 1998 Apr; 21(4):196-200. PubMed ID: 9649059
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
[TBL] [Abstract][Full Text] [Related]
5. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
6. Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.
Reach I; Luong N; Chastang C; Chakroun M; Mirshahi S; Mirshahi MC; Soria J; Desmichels D; Baumelou A
Artif Organs; 2001 Jul; 25(7):591-5. PubMed ID: 11493282
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin Fraxiparin in chronic hemodialysis. A dose-finding study.
Morinière P; Dieval J; Bayrou B; Roussel B; Renaud H; Fournier A; Delobel J
Blood Purif; 1989; 7(6):301-8. PubMed ID: 2558691
[TBL] [Abstract][Full Text] [Related]
8. A low molecular weight heparin in hemodialysis.
Maurin N; Kierdorf H
Klin Wochenschr; 1988 Mar; 66(6):246-9. PubMed ID: 2835544
[TBL] [Abstract][Full Text] [Related]
9. [Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine].
Bara L; Combe-Tamzali S; Conard J; Horellou MH; Samama M
J Mal Vasc; 1987; 12 Suppl B():78-84. PubMed ID: 2834498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antithrombotic activity of two heparin fragments PK 10169 (mol. wt. 5,000) and EMT 680 (mol. wt. 2,500) and unfractionated heparin in a rabbit experimental thrombosis model: relative importance of systemic anti-Xa and anti-IIa activities.
Bara L; Trillou M; Mardiguian J; Samama M
Nouv Rev Fr Hematol (1978); 1986; 28(6):355-8. PubMed ID: 3562219
[TBL] [Abstract][Full Text] [Related]
11. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers.
Barrett JS; Hainer JW; Kornhauser DM; Gaskill JL; Hua TA; Sprogel P; Johansen K; van Lier JJ; Knebel W; Pieniaszek HJ
Thromb Res; 2001 Feb; 101(4):243-54. PubMed ID: 11248285
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
14. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study.
Kessler M; Gangemi C; Gutierrez Martones A; Lacombe JL; Krier-Coudert MJ; Galland R; Kielstein JT; Moureau F; Loughraieb N
Hemodial Int; 2013 Apr; 17(2):282-93. PubMed ID: 22925178
[TBL] [Abstract][Full Text] [Related]
15. Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration.
Dawes J; Bara L; Billaud E; Samama M
Haemostasis; 1986; 16(2):116-22. PubMed ID: 3710290
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.
Shinoda T; Arakura H; Katakura M; Shirota T; Nakagawa S
Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis.
Mestre M; Clairefond P; Mardiguian J; Trillou M; Le Fur G; Uzan A
Thromb Res; 1985 May; 38(4):389-99. PubMed ID: 4012669
[TBL] [Abstract][Full Text] [Related]
18. Use of low-dose low molecular weight heparin in hemodialysis.
Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
[TBL] [Abstract][Full Text] [Related]
19. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
Suzuki T; Ota K; Naganuma S; Koshikawa S; Hirasawa Y; Nakagawa S; Otsubo O; Akizawa T
Semin Thromb Hemost; 1990 Oct; 16 Suppl():46-54. PubMed ID: 1962904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
